Last updated: 2026-09-16 09:45:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Seer, Inc. (SEER) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $1.91, with a market capitalisation of $105.76M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.55 to $2.41. This page covers its latest market performance, valuation, price trends and company information.
$105.76M | |
$1.90 | |
$86.55 | |
$1.46 | |
$1.91 | |
175.42K | |
1.07M | |
-- | |
$2.41 | |
$1.55 | |
-- | |
-- |
Seer, Inc. (SEER) is trading at $1.92 in pre-market trading as of 2026-09-15 19:59:19, up 0.26% ($0.01) from the previous close of $1.91
Pre-market trading shows how investors are pricing SEER before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Seer, Inc. (SEER) moved from $1.95 to $1.91, representing a decline of 2.31% ($0.04).
The stock traded between $1.89 and $1.98 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 141.39 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 41.3%
SEER is currently trading at $1.91, placing it 41.3% of the way from its 52-week low of $1.55 to its 52-week high of $2.41. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 124 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Seer, Inc. (SEER) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.